Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BK Giulini, a subsidiary of the ICL Group, is a specialized manufacturer of chemical products and pharmaceutical ingredients headquartered in Ludwigshafen, Germany. The company is globally recognized for its expertise in producing high-quality antacid active pharmaceutical ingredients (APIs), including hydrotalcite, magaldrate, and aluminum hydroxide. Beyond APIs, BK Giulini provides a comprehensive portfolio of phosphate-based excipients and specialty additives tailored for the pharmaceutical, food, and industrial sectors. Their manufacturing facilities operate under stringent GMP guidelines, ensuring compliance with international pharmacopeia standards such as USP and EP. As a key player in the gastrointestinal health market, the company supports global pharmaceutical firms with reliable raw materials for over-the-counter and prescription medications. With a history dating back to the 19th century, BK Giulini combines long-standing industrial tradition with modern chemical innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Giulini.